Chief Physician, Professor, Doctoral Supervisor, Vice President and Director of the Department of Reproductive Medicine at Peking University Third Hospital.
Affiliated HospitalPeking University Third Hospital (PKU Third Affiliated Hospital)
→
Research areas: Reproductive endocrine disorders (polycystic ovary syndrome, primary ovarian insufficiency), female fertility assessment and protection, treatment of thin endometrium, and recurrent implantation failure in assisted reproductive technologies.
Cutting-edge technologies: First internationally reported the crucial role of elevated levels of autoimmune antibodies JO-1 and PR3 in the pathogenesis of primary ovarian insufficiency, and discovered that mitochondrial MT-CO1 gene mutations are one of the important causes of the disease. Led the world's first registered clinical trial, "Autologous fat vascular matrix component intrauterine perfusion for the treatment of thin endometrium," increasing the assisted pregnancy rate to 3% in women with damaged endometrium who do not respond to conventional treatments. Led the development of OvaRePred, the world's first AI tool for ovarian function assessment, which has been used by over 20,000 people in more than 42 countries and regions worldwide.
Areas of expertise: Polycystic ovary syndrome, female fertility assessment and protection, recurrent implantation failure in assisted reproductive technology treatment, and infertility.
Academic Highlights and Core Values: Recipient of the National Science Fund for Distinguished Young Scholars; Chairman-elect of the Reproductive Medicine Branch of the Chinese Medical Association; Vice President of the Asia-Pacific Society for Reproductive Medicine. He has led multiple national key research projects, published 12 papers in top international journals such as *Lancet* and *Nature*, and edited 13 monographs. He has participated in the development of 2 international guidelines and spearheaded the development of 17 Chinese expert consensus and clinical guidelines. He has received numerous national and provincial-level honors, including the National Science and Technology Progress Award and the National Natural Science Award, and has achieved 15 technology transfers. In 2022, he was awarded the title of "Capital Health Guardian."
Yu Jiakuo
Professor, Doctoral Supervisor (Director of Knee Surgery)
Research areas : knee cruciate ligament, meniscus, and cartilage injuries; Cutting-edge technologies: ACL personalized adjustable bone tunnel anatomical reconstruction, meniscus suture preservation techniques; Areas of expertise: anterior/posterior cruciate ligament rupture, meniscus tear, knee cartilage injury; Academic highlights: Domestic authority in the field of knee cruciate ligaments, internationally pioneering ACL femoral bone tunnel positioning landmarks; Core values: Innovating cruciate ligament reconstruction surgical concepts and optimizing individualized anatomical reconstruction techniques.
Liu Zhongjun
Chief Physician, Professor, Doctoral Supervisor, Senior Expert in Orthopedics at Peking University Third Hospital.
Research areas: Diagnosis and treatment of spinal degenerative diseases (cervical spondylosis, lumbar spondylolisthesis, lumbar spinal stenosis, etc.), spinal tumors, spinal deformities, trauma, and minimally invasive surgery, with particular expertise in the surgical treatment of complex spinal conditions.
Cutting-edge technology: In 2014, the team completed the world's first case of using a 3D-printed, custom-made axis vertebra for spinal tumor treatment. Holding a nationally authoritative position in the field of spinal tumors, the spinal group has performed over 2400 spinal tumor surgeries since 2005, leading the country in both the number of surgeries and success rate, with therapeutic effects reaching international advanced levels. The team was among the first in China to perform endoscopic cervical discectomy and fusion.
Specializes in treating: spinal tumors, cervical spondylosis, lumbar spondylolisthesis, lumbar spinal stenosis, spinal deformities, and spinal trauma.
Academic Highlights and Core Values: The world's first 3D-printed, custom-made axis vertebra was completed, marking China's leading position in the field of 3D-printed orthopedic implants. It has international academic influence in the field of spinal tumor surgery, providing spinal tumor patients with the "Peking University Medical Center Solution" for precise resection and functional reconstruction.